Risk factors associated with HCV infection in semi-rural areas of central Greece

European Journal of Internal Medicine

Volumn 18, Issue 1, 2007, Pages 48-55

  Gatselis, Nikolaos K ^a   Rigopoulou, Eirini ^a,b   Stefos, Aggelos ^b   Kardasi, Maria ^c   Dalekos, Georgios N ^a,b  

^a Medical School   (Greece)

^b Medical School   (Greece)

^c General Hospital of Volos   (Greece)

Author keywords

Community acquired hepatitis C virus infection; Hepatitis C virus; Non disposable, multiple use glass syringe; Risk factors; Transmission

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE TRANSMISSION; FEMALE; GEOGRAPHIC DISTRIBUTION; GREECE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LOGISTIC REGRESSION ANALYSIS; MALE; MEDICAL INSTRUMENTATION; MEDICAL RECORD REVIEW; MORBIDITY; RETROSPECTIVE STUDY; RISK FACTOR; RURAL AREA; STATISTICAL SIGNIFICANCE; SYRINGE;

EID: 33846036273     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2006.09.008     Document Type: Article

References (36)

1. Memon M.I., and Memon M.A. Hepatitis C: an epidemiological review. J Viral Hepat 9 (2002) 84-100
2. Liang T.J., Rehermann B., Seeff L.B., and Hoofnagle J.H. Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann Intern Med 132 (2000) 296-305
3. Colombo M. Natural history and pathogenesis of hepatitis C virus related hepatocellular carcinoma. J Hepatol 31 Suppl 1 (1999) 25-30
4. Wasley A., and Alter M.J. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis 20 (2000) 1-16
5. Sypsa V., Hadjipaschali E., and Hatzakis A. Prevalence, risk factors and evaluation of a screening strategy for chronic hepatitis C and B virus infections in healthy company employees. Eur J Epidemiol 17 (2001) 721-728
6. Gogos C.A., Fouka K.P., Nikiforidis G., et al. Prevalence of hepatitis B and C virus infection in the general population and selected groups in South-Western Greece. Eur J Epidemiol 18 (2003) 551-557
7. Dalekos G.N., Zervou E., Merkouropoulos M.H., and Tsianos E.V. Prevalence of hepatitis B and C viruses infection in chronic alcoholics with or without liver disease in Ioannina, Greece: low incidence of HCV infection. Eur J Epidemiol 12 (1996) 21-25
8. Zervou E.K., Boumba D.S., Liaskos C., Georgiadou S., Tsianos E.V., and Dalekos G.N. Low prevalence of HCV, HIV, and HTLV-I/II infection markers in northwestern Greece: results of a 3-year prospective donor study (1995-1997). Eur J Intern Med 14 (2003) 39-44
9. Koulentaki M., Ergazaki M., Moschandrea J., et al. Prevalence of hepatitis B and C markers in high-risk hospitalized patients in Crete: a five-year observational study. BMC Public Health 1 (2001) 17
10. Lionis C., Vlachonikolis I.G., Skliros S., Symeonidis A., Merkouris B.P., and Kouroumalis E. Do undefined sources of hepatitis C transmission exist? The Greek study in general practice. J Viral Hepat 7 (2000) 218-224
11. Lionis C., Frangoulis E., Koulentakis M., Biziagos E., and Kouroumalis E. Prevalence of hepatitis A, B, and C markers in school children of a rural area of Crete, Greece. Eur J Epidemiol 13 (1997) 417-420
12. Goritsas C., Plerou I., Agaliotis S., et al. HCV infection in the general population of a Greek island: prevalence and risk factors. Hepatogastroenterology 47 (2000) 782-785
13. Lionis C., Koulentaki M., Biziagos E., and Kouroumalis E. Current prevalence of hepatitis A, B and C in a well-defined area in rural Crete, Greece. J Viral Hepat 4 (1997) 55-61
14. Koulentaki M., Spanoudakis S., Kantidaki E., et al. Prevalence of hepatitis B and C markers in volunteer blood donors in Crete. A 5-year study. J Viral Hepat 6 (1999) 243-248
15. Dalekos G.N., Zervou E., Karabini F., and Tsianos E.V. Prevalence of viral markers among refuges from southern Albania: increased incidence of infection with hepatitis A, B and D viruses. Eur J Gastroenterol Hepatol 7 (1995) 553-558
16. Gordon S.C., Elloway R.S., Long J.C., and Dmuchowski C.F. The pathology of hepatitis C as a function of mode of transmission: blood transfusion vs. intravenous drug use. Hepatology 18 (1993) 1338-1343
17. Dalekos G.N., Manoussakis M.N., Zervou E., Tsianos E.V., and Moutsopoulos H.M. Immunologic and viral markers in the circulation of anti-HIV negative heroin addicts. Eur J Clin Invest 23 (1993) 219-225
18. Kao J.H., and Chen D.S. Transmission of hepatitis C virus in Asia: past and present perspectives. J Gastroenterol Hepatol 15 (2000) 91-96 [Suppl]
19. Zachou K., Liaskos C., Christodoulou D.K., et al. Anti-cardiolipin antibodies in patients with chronic viral hepatitis are independent of beta2-glycoprotein I cofactor or features of antiphospholipid syndrome. Eur J Clin Invest 33 (2003) 161-168
20. Neuschwander-Tetri B.A., and Caldwell S.H. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 37 (2003) 1202-1219
21. Alvarez F., Berg P.A., Bianchi F.B., et al. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31 (1999) 929-938
22. Zachou K., Rigopoulou E., and Dalekos G.N. Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease. J Autoimmune Dis 1 1 (2004) 2
23. Kyriakou D.S., Alexandrakis M.G., Zachou K., Passam F., Stathakis N.E., and Dalekos G.N. Hemopoietic progenitor cells and bone marrow stromal cells in patients with autoimmune hepatitis type 1 and primary biliary cirrhosis. J Hepatol 39 (2003) 679-685
24. Tsikrikoni A., Kyriakou D.S., Rigopoulou E., et al. Markers of cell activation and apoptosis in bone marrow mononuclear cells of patients with autoimmune hepatitis type 1 and primary biliary cirrhosis. J Hepatol 42 (2005) 393-399
25. Zachou K., Liaskos C., Rigopoulou E., et al. Presence of high avidity anticardiolipin antibodies in patients with autoimmune cholestatic liver diseases. Clin Immunol 119 (2006) 203-212
26. Poupon R., Chazouilleres O., and Poupon R.E. Chronic cholestatic diseases. J Hepatol 32 (2000) 129-140
27. Simmonds P., McOmish F., Yap P.L., et al. Sequence variability in the 5′ non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity. J Gen Virol 74 (1993) 661-668
28. Maio G., d' Argenio P., Stroffolini T., et al. Hepatitis C virus infection and alanine transaminase levels in the general population: a survey in a southern Italian town. J Hepatol 33 (2000) 116-120
29. Guadagnino V., Stroffolini T., Rapicetta M., et al. Prevalence, risk factors and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy. Hepatology 26 (1997) 1106-1111
30. Chiaramonte M., Stroffolini T., Lorenzoni U., et al. Risk factors in community-acquired chronic hepatitis C virus infection: a case-control study in Italy. J Hepatol 24 (1996) 129-134
31. Sun C.-A., Chen H.-C., Lu C.-F., et al. Transmission of hepatitis C virus in Taiwan: prevalence and risk factors based on a nationwide survey. J Med Virol 59 (1999) 290-296
32. Raffaele A., Valenti M., Iovenitti M., et al. High prevalence of HCV infection among the general population in a rural area of central Italy. Eur J Epidemiol 17 (2001) 41-46
33. Chen T.Z., Wu J.C., Yen F.S., et al. Injection with nondisposable needles as an important route for transmission of acute community-acquired hepatitis C virus infection in Taiwan. J Med Virol 46 (1995) 247-251
34. Sun C.-A., Chen H.-C., Lu S.-N., et al. Persistent hyperendemicity of hepatitis C virus infection in Taiwan: the important role of iatrogenic risk factors. J Med Virol 65 (2001) 30-34
35. Stroffolini T., Lorenzoni U., Menniti-Ippolito F., Infantolino D., and Chiaramonte M. Hepatitis C virus infection in spouses: sexual transmission or common exposure to the same risk factors?. Am J Gastroenterol 96 (2001) 3138-3141
36. Alter M.J. Prevention of spread of hepatitis C. Hepatology 36 Suppl 1 (2002) S93-S98